0
0
For a time last month, scientific research in the United States came to a halt.
On January 22, the Trump administration directed federal health and science agencies—including the National Institutes of Health (NIH), National Science Foundation (NSF), and Centers for Disease Control and Prevention (CDC)—to pause external communications, meetings, and travel. A freeze was also placed on federal grants, preventing new research projects from starting and canceling key grant reviews that determine the allocation of government research funding.
Two weeks later, some of these freezes were lifted, yet the research community remained in turmoil. Then, on February 7, the administration announced additional funding restrictions, including capping “indirect costs” at 15% of grant totals. These funds, which typically help institutions cover overhead expenses like facilities, equipment, and administrative support, would be drastically reduced.
Now, legal battles are unfolding. By February 12, the NIH signaled it might reverse these restrictions, issuing an internal memo stating that the administration’s objectives would be “effectuated over time.”
But the uncertainty left in the wake of these abrupt changes has rattled scientists across the country.
The Impact on Research Institutions
The NIH funds over 50,000 grants annually, supporting at least 300,000 scientists at more than 2,500 institutions. Traditionally, around 30% of each grant is allocated to cover indirect costs—some universities take as much as 50% or more.
Institutions such as the University of Pennsylvania and Stanford University have expressed concerns about the proposed 15% cap. Penn estimated losses of $240 million annually, while Stanford projected a $160 million reduction. Such funding cuts, scientists argue, would significantly hinder ongoing research efforts.
Dr. Jason Shepherd, a neurobiology professor at the University of Utah, warned, “The sudden change and the flat rate mean no one could plan for it and mitigate the impact. We can only hope that change, when it happens at the NIH, will be more thoughtful and inclusive of all stakeholders.”
Lawsuits and Ongoing Uncertainty
The backlash against these measures has been swift. As of February 10, 22 states have filed lawsuits to block the administration’s indirect cost cap, arguing that cutting such funding would derail critical research in fields such as medicine and public health. The lawsuit states, “Without relief from NIH’s action, these institutions’ cutting-edge work to cure and treat human disease will grind to a halt.”
Meanwhile, the research community continues to grapple with the aftershocks of the freezes and funding cuts. The NIH and other federal agencies are major sources of research funding, and any pause or reduction in grants creates ripple effects that can stall scientific progress.
Dr. Monica Bertagnolli, former NIH director, emphasized the long-term damage these disruptions can cause: “Preventing NIH from issuing research funding by stopping ongoing grant proposal reviews and the work of congressionally mandated advisory committees—even temporarily—can have a devastating effect on our nation’s long-term research productivity and success.”
A Future Clouded by Speculation
Even as some research funding has been restored, scientists remain cautious. Many institutions have instructed researchers not to speak publicly about their funding situations, leaving many questions unanswered. Some researchers declined to comment for this article due to institutional restrictions.
“The freezing and pausing and delays are creating chaos and confusion, not actually improving scientific review,” said Dr. Darby Saxbe, a psychology professor at the University of Southern California.
Despite the uncertainty, one thing remains clear: science in the U.S. is facing a period of upheaval. The coming months will determine whether these policy shifts will have lasting consequences on the country’s scientific research landscape.
Disclaimer: This article is based on publicly available information and expert opinions. The policies and decisions described are subject to change as legal challenges unfold and government agencies adjust their strategies. Readers are encouraged to follow official sources for the most up-to-date developments.
